Emma Walmsley

Director/Board Member at MICROSOFT CORPORATION

Net worth: 359 M $ as of 30/04/2026

57 year

60 connections

Consumer Non-Durables

Health Technology

Finance

Profile

Emma N.
Walmsley is currently Chief Executive Officer at GlaxoSmithKline Australia Pty Ltd. and Group President & Chief Executive Officer at GlaxoSmithKline Korea Ltd. She serves as an Independent Director at Microsoft Corp.
since 2019 and is a Member of Stanford Medicine.
Formerly, Ms. Walmsley was Chief Executive Officer at GlaxoSmithKline Consumer Healthcare Pte Ltd. and Haleon UK Holdings Ltd. She was Chief Executive Officer & Executive Director at GSK Plc from 2017 to 2025, Non-Executive Director at Diageo Plc in 2016, Director at Haleon UK Holdings (No.2) Ltd. from 2019 to 2022, General Manager-Consumer Products at L'Oreal (China) Co., Ltd., and Global Brand Head at Maybelline LLC from 2002 to 2007.
Ms. Walmsley graduated from the University of Oxford.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GSK PLC 0.33%	09/12/2025	1,35,60,795 ( 0.33% )	355 M $	30/04/2026
MICROSOFT CORPORATION 0%	12/03/2026	9,913 ( 0% )	4 M $	30/04/2026

Latest news about Emma Walmsley

11/12	Outgoing GSK CEO Emma Walmsley declares US best place to invest	AN
08/11	Diageo has considered external candidates for CEO role, FT reports	RE
08/11	Diageo considers external candidates for CEO role, including outgoing GSK boss, FT reports	RE
29/25/29	GSK Lifts Guidance After Specialty Medicines Boost Sales -- Update	DJ
29/25/29	GSK lifts sales and profit outlook as Specialty Medicines unit shines	AN

Emma Walmsley active positions

Companies	Position	Start
MICROSOFT CORPORATION	Director/Board Member	01/12/2019
Glaxosmithkline Australia Pty Ltd. Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, vaccines and consumer healthcare products	Chief Executive Officer	-
Stanford Medicine Stanford Medicine Hospital/Nursing ManagementHealth Services Operates as a medical school	Corporate Officer/Principal	-
GlaxoSmithKline Korea Ltd. GlaxoSmithKline Korea Ltd. Medical DistributorsDistribution Services Wholesales drugs, cosmetics and medical devices	Chief Executive Officer	-

All active positions of Emma Walmsley

Former positions of Emma Walmsley

Companies	Position	End
GSK PLC	Chief Executive Officer	31/12/2025
Haleon UK Holdings (No.2) Ltd. Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company	Director/Board Member	18/07/2022
DIAGEO PLC	Director/Board Member	21/09/2016
Maybelline LLC Maybelline LLC Household/Personal CareConsumer Non-Durables Manufactures cosmetics and beauty products	Corporate Officer/Principal	01/01/2007
GlaxoSmithKline Consumer Healthcare Pte Ltd. GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Manufacutures and distributes healthcare foods, drugs, pharmaceuticals and dairy products	Chief Executive Officer	-

See the detail of Emma Walmsley's experience

Training of Emma Walmsley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emma Walmsley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Microsoft Corp. Microsoft Corp. Packaged SoftwareTechnology Services Develops, manufactures and distributes software products	Technology Services
Diageo Plc Diageo Plc Beverages: AlcoholicConsumer Non-Durables Produces, distributes and sells wine, beer and other beverages	Consumer Non-Durables
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Maybelline LLC Maybelline LLC Household/Personal CareConsumer Non-Durables Manufactures cosmetics and beauty products	Consumer Non-Durables
L'Oreal (China) Co., Ltd. L'Oreal (China) Co., Ltd. Household/Personal CareConsumer Non-Durables Manufactures and markets personal care products	Consumer Non-Durables
GlaxoSmithKline Consumer Healthcare Pte Ltd. GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Manufacutures and distributes healthcare foods, drugs, pharmaceuticals and dairy products	Consumer Non-Durables
GlaxoSmithKline Korea Ltd. GlaxoSmithKline Korea Ltd. Medical DistributorsDistribution Services Wholesales drugs, cosmetics and medical devices	Distribution Services
GlaxoSmithKline Consumer Healthcare Holdings Ltd. GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company	Finance
Glaxosmithkline Australia Pty Ltd. Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, vaccines and consumer healthcare products	Health Technology
Haleon UK Holdings (No.2) Ltd. Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company	Finance
Stanford Medicine Stanford Medicine Hospital/Nursing ManagementHealth Services Operates as a medical school	Health Services